Uncategorized

Attovia adds to biotech IPO momentum with $289M offering

Published

on

The startup is the 12th drug company to bank at least $250 million in an IPO this year, nearly matching totals last seen during the sector’s pandemic peak, according to BioPharma Dive data.

Leave a Reply

Your email address will not be published. Required fields are marked *

Trending

Exit mobile version